Description
Empavrixa-M 500 is a combination pharmaceutical formulation containing Empagliflozin and Metformin Hydrochloride Tablets. This combination is used under medical supervision for the management of Type 2 Diabetes Mellitus.
Empagliflozin belongs to the SGLT2 inhibitor class, while Metformin is a biguanide antidiabetic medicine. Their complementary mechanisms can help improve blood glucose control in suitable patients when prescribed along with appropriate diet, exercise and lifestyle measures.
Composition
Empagliflozin + Metformin Hydrochloride Tablets
Note: The exact strength of each active ingredient should be added according to the approved product specification/pack artwork. The image identifies the product as Empavrixa-M 500, but does not clearly state the complete individual strengths.
Uses and Indications
Empagliflozin and Metformin Hydrochloride Tablets may be prescribed for:
- Management of Type 2 Diabetes Mellitus
- Improving blood glucose control
- Supporting glycemic control along with diet and exercise
- Patients requiring combination antidiabetic therapy
- Supporting overall metabolic management in appropriate patients
The product should be used only according to the advice of a qualified healthcare professional.
Benefits of Empagliflozin + Metformin
The combination of Empagliflozin and Metformin provides complementary approaches to blood glucose management:
- Helps control elevated blood glucose levels
- Combines two different antidiabetic mechanisms
- Helps improve insulin-related glucose management
- May support weight-management goals in appropriate patients
- Empagliflozin therapy may provide cardiovascular and renal benefits in certain patient populations
How Does Empavrixa-M 500 Work?
Empagliflozin works by inhibiting the SGLT2 protein in the kidneys. This reduces glucose reabsorption and increases the amount of glucose eliminated through urine.
Metformin primarily reduces glucose production by the liver and improves the body’s response to insulin.
Together, these medicines can help improve glycemic control in appropriate patients with Type 2 Diabetes.
Dosage and Administration
The dosage of Empavrixa-M 500 should be determined by the treating physician based on the patient’s medical condition, blood glucose levels, kidney function and other medications.
Take the medicine exactly as prescribed. Do not change the dose or discontinue treatment without consulting your doctor.
Possible Side Effects
Some patients may experience:
- Nausea
- Diarrhea
- Stomach discomfort
- Increased urination
- Urinary tract infections
- Genital infections
- Dehydration
- Headache
If side effects are severe, persistent or concerning, seek medical advice.
Precautions
Before taking Empagliflozin and Metformin Hydrochloride Tablets, inform your doctor about your medical history and all medicines you are taking.
Patients with kidney problems, dehydration or other relevant medical conditions may require special medical evaluation before and during treatment.
This is a prescription medicine and should be used under medical supervision.
Product Details
| Parameter | Details |
|---|---|
| Brand Name | Empavrixa-M 500 |
| Composition | Empagliflozin + Metformin Hydrochloride |
| Dosage Form | Tablets |
| Therapeutic Category | Antidiabetic |
| Indication | Type 2 Diabetes Mellitus |
| Prescription | Prescription Medicine |
| Pack Size | 10 × 10 Tablets |
| MRP Shown | ₹175 per strip |
Frequently Asked Questions
1. What is Empavrixa-M 500?
Empavrixa-M 500 is a combination tablet containing Empagliflozin and Metformin Hydrochloride, used for the management of Type 2 Diabetes Mellitus under medical supervision.
2. What is the composition of Empavrixa-M 500?
The product contains Empagliflozin and Metformin Hydrochloride.
3. What is Empavrixa-M 500 used for?
It is used to help manage Type 2 Diabetes Mellitus and improve blood glucose control when prescribed by a healthcare professional.
4. How does Empagliflozin work?
Empagliflozin helps lower blood glucose by reducing glucose reabsorption in the kidneys, allowing more glucose to be eliminated through urine.
5. What is the role of Metformin?
Metformin primarily decreases glucose production by the liver and improves insulin sensitivity.
6. Can Empavrixa-M 500 be taken without a doctor’s advice?
No. It should be taken according to the prescription and guidance of a qualified healthcare professional.
7. Who markets Empavrixa-M 500?
Empavrixa-M 500 is marketed by Rapid Life Drugs & Healthcare.
